Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.53) by 11.32 percent. This is a 11.32 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $2.593 million which missed the analyst consensus estimate of $8.784 million by 70.48 percent. This is a 59.94 percent decrease over sales of $6.473 million the same period last year.